Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Moore

Showing results (341-350 of 540) with videos related to

Pageof 54
Sort By:
Biotechnology and Bioengineering|January 9, 2013
Pulsed electric field (PEF) as an intensification pretreatment for greener solvent lipid extraction from microalgaeMauricio D Antezana Zbinden, Belinda S M Sturm, Ryan D Nord, et al.
Archives of Sexual Behavior|December 18, 2016
A Latent Class Analysis of Seroadaptation Among Gay and Bisexual MenKiffer G Card, Nathan J Lachowsky, Zishan Cui, et al.
BMJ (Clinical Research Ed.)|November 15, 2011
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness studyJames G Kahn, Elliot Marseille, David Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrheaJames D Campbell, David Moore, Richard Degerman, et al.
The Lancet. Global Health|March 4, 2017
Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysisAna Requena-Méndez, Sheila Bussion, Edelweiss Aldasoro, et al.
AIDS Patient Care and Stds|September 10, 2008
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural UgandaPaul J Weidle, David Moore, Jonathan Mermin, et al.
Journal of Neurovirology|May 20, 2018
A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioningMaría J Marquine, Ilse Flores, Rujvi Kamat, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 9, 2004
Inflammatory bowel disease: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and NutritionSimon H Murch, Robert Baldassano, Hans Buller, et al.
ACS Nano|January 23, 2023
Precision Modification of Monolayer Transition Metal Dichalcogenides via Environmental E-Beam PatterningRyan Selhorst, Zhuohang Yu, David Moore, et al.
AIDS Research and Therapy|May 26, 2006
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAARTViviane D Lima, Patricia Kretz, Anita Palepu, et al.
Pageof 54

Showing results (341-350 of 540) with videos related to

Sort By:
Pageof 54
Biotechnology and Bioengineering|January 9, 2013
Pulsed electric field (PEF) as an intensification pretreatment for greener solvent lipid extraction from microalgaeMauricio D Antezana Zbinden, Belinda S M Sturm, Ryan D Nord, et al.
Archives of Sexual Behavior|December 18, 2016
A Latent Class Analysis of Seroadaptation Among Gay and Bisexual MenKiffer G Card, Nathan J Lachowsky, Zishan Cui, et al.
BMJ (Clinical Research Ed.)|November 15, 2011
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness studyJames G Kahn, Elliot Marseille, David Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrheaJames D Campbell, David Moore, Richard Degerman, et al.
The Lancet. Global Health|March 4, 2017
Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysisAna Requena-Méndez, Sheila Bussion, Edelweiss Aldasoro, et al.
AIDS Patient Care and Stds|September 10, 2008
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural UgandaPaul J Weidle, David Moore, Jonathan Mermin, et al.
Journal of Neurovirology|May 20, 2018
A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioningMaría J Marquine, Ilse Flores, Rujvi Kamat, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 9, 2004
Inflammatory bowel disease: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and NutritionSimon H Murch, Robert Baldassano, Hans Buller, et al.
ACS Nano|January 23, 2023
Precision Modification of Monolayer Transition Metal Dichalcogenides via Environmental E-Beam PatterningRyan Selhorst, Zhuohang Yu, David Moore, et al.
AIDS Research and Therapy|May 26, 2006
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAARTViviane D Lima, Patricia Kretz, Anita Palepu, et al.
Pageof 54